2,171 reports of this reaction
1.2% of all ANTACID reports
#20 most reported adverse reaction
WHEEZING is the #20 most commonly reported adverse reaction for ANTACID, manufactured by CVS Pharmacy. There are 2,171 FDA adverse event reports linking ANTACID to WHEEZING. This represents approximately 1.2% of all 184,150 adverse event reports for this drug.
Patients taking ANTACID who experience wheezing should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WHEEZING is a less commonly reported adverse event for ANTACID, but still significant enough to appear in the safety profile.
In addition to wheezing, the following adverse reactions have been reported for ANTACID:
The following drugs have also been linked to wheezing in FDA adverse event reports:
WHEEZING has been reported as an adverse event in 2,171 FDA reports for ANTACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
WHEEZING accounts for approximately 1.2% of all adverse event reports for ANTACID, making it a notable side effect.
If you experience wheezing while taking ANTACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.